Cargando…

Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation

Detalles Bibliográficos
Autores principales:	Sanomachi, Tomomi, Sumiyoshi Okuma, Hitomi, Yonemori, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015125/ https://www.ncbi.nlm.nih.gov/pubmed/37235182 http://dx.doi.org/10.1007/s13691-023-00600-2

Ejemplares similares

COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster
por: Singh, Arminder, et al.
Publicado: (2022)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation
por: Mahgoub, Abdullahi E, et al.
Publicado: (2022)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
por: Doria-Rose, Nicole A., et al.
Publicado: (2021)

Isometric Contraction of an Upper Extremity and Its Effects on the Contralateral Lower Extremity
por: Lee, Daehee, et al.
Publicado: (2014)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine
por: Mesina, Flordeluna Z.
Publicado: (2022)

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021
por: Lin, Kuan-Yin, et al.
Publicado: (2022)

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
por: Kim, Beop Chang, et al.
Publicado: (2022)

(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient
por: Sindu, D., et al.
Publicado: (2023)

COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review
por: Agustin, Maulidina, et al.
Publicado: (2023)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

mrna-1273: Erythema nodosum: case report
Publicado: (2021)

mrna-1273: Immediate hypersensitivity: case report
Publicado: (2021)

mrna-1273: Acute myocarditis: case report
Publicado: (2021)

mRNA-1273: Myopericarditis: case report
Publicado: (2021)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
por: Chu, Laurence, et al.
Publicado: (2022)

Multiple Evanescent White Dot Syndrome Developing Three Days following Administration of mRNA-1273 Booster Vaccine: Case Report
por: Alhabshan, Rashed, et al.
Publicado: (2022)

Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report
por: Claes, Kathleen J., et al.
Publicado: (2023)

Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers
por: Hasibuan, Anshari Saifuddin, et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

Boosters appear effective, but are they always needed?
por: Reddy, K Srinath
Publicado: (2021)

Contralateral compartment syndrome inoculated by invasive group A streptococcus
por: Chen, Huiwen, et al.
Publicado: (2016)

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population
por: Noda-Narita, Shoko, et al.
Publicado: (2019)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
por: Patyna, Sammy, et al.
Publicado: (2022)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

mRNA-1273: Various toxicities: case report
Publicado: (2021)

mrna-1273/tozinameran: Myocarditis: 8 case reports
Publicado: (2021)

mrna-1273: Minimal change disease: case report
Publicado: (2021)

mRNA-1273: Thyroiditis: 3 case reports
Publicado: (2021)

mrna-1273: Bullous drug eruption: case report
Publicado: (2021)

mMRNA-1273: Autoimmune hepatitis: case report
Publicado: (2021)

mRNA-1273: Autoimmune hepatitis: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tbg3is7njl857e9teq9f7388o